Literature DB >> 26359144

A reappraisal of vitamin D effect on non-skeletal targets and mortality.

S Minisola1, C Cipriani2, M Cilli2, A Scillitani3, J Pepe2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26359144     DOI： 10.1007/s40618-015-0387-3

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  25 in total

1.  Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438).

Authors:  Alison Avenell; Jonathan A Cook; Graeme S Maclennan; Gladys C Macpherson
Journal:  Age Ageing       Date:  2007-08-15       Impact factor: 10.668

2.  Effect of Vitamin D Supplementation on Glycemic Control in Patients With Type 2 Diabetes (SUNNY Trial): A Randomized Placebo-Controlled Trial.

Authors:  Yvonne H M Krul-Poel; Sanne Westra; Edwin ten Boekel; Marieke M ter Wee; Natasja M van Schoor; Hans van Wijland; Frank Stam; Paul T A M Lips; Suat Simsek
Journal:  Diabetes Care       Date:  2015-05-13       Impact factor: 19.112

3.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.

Authors:  Joann E Manson; Shari S Bassuk; I-Min Lee; Nancy R Cook; Michelle A Albert; David Gordon; Elaine Zaharris; Jean G Macfadyen; Eleanor Danielson; Jennifer Lin; Shumin M Zhang; Julie E Buring
Journal:  Contemp Clin Trials       Date:  2011-10-02       Impact factor: 2.226

Review 4.  Effects of vitamin D supplements on bone density.

Authors:  Ian R Reid
Journal:  J Endocrinol Invest       Date:  2014-07-20       Impact factor: 4.256

5.  Low vitamin D and hypertension: a causal association?

Authors:  Shoaib Afzal; Børge G Nordestgaard
Journal:  Lancet Diabetes Endocrinol       Date:  2014-06-25       Impact factor: 32.069

Review 6.  Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis.

Authors:  Sang Yhun Ju; Hyun Suk Jeong; Do Hoon Kim
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

7.  Hypovitaminosis D in primary hyperparathyroidism: to treat or not to treat? That is the question.

Authors:  Salvatore Minisola; Elisabetta Romagnoli; Alfredo Scillitani; Sudhakar D Rao
Journal:  J Endocrinol Invest       Date:  2014-03-20       Impact factor: 4.256

Review 8.  Toward a physiological referent for the vitamin D requirement.

Authors:  R P Heaney
Journal:  J Endocrinol Invest       Date:  2014-10-12       Impact factor: 4.256

Review 9.  Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study.

Authors:  Shoaib Afzal; Peter Brøndum-Jacobsen; Stig E Bojesen; Børge G Nordestgaard
Journal:  Lancet Diabetes Endocrinol       Date:  2014-01-28       Impact factor: 32.069

10.  Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts.

Authors:  Shoaib Afzal; Peter Brøndum-Jacobsen; Stig E Bojesen; Børge G Nordestgaard
Journal:  BMJ       Date:  2014-11-18
View more
  3 in total

Review 1.  Oral calcidiol is a good form of vitamin D supplementation.

Authors:  Piergianni Biondi; Jessica Pepe; Federica Biamonte; Marco Occhiuto; Martina Parisi; Chiara Demofonti; Valeria Baffa; Salvatore Minisola; Cristiana Cipriani
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

2.  Making sense of vitamin D concentrations.

Authors:  Florin M Musteata
Journal:  Future Sci OA       Date:  2016-01-13

3.  Lumbar spine bone mineral density and trabecular bone score-adjusted FRAX, but not FRAX without bone mineral density, identify subclinical carotid atherosclerosis.

Authors:  J Pepe; G Della Grotta; R Santori; V De Martino; M Occhiuto; M Cilli; S Minisola; C Cipriani
Journal:  J Endocrinol Invest       Date:  2021-02-12       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.